↓ Skip to main content

Cannabinoid treatment for autism: a proof-of-concept randomized trial

Overview of attention for article published in Molecular Autism, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#38 of 719)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
6 news outlets
twitter
87 X users
facebook
2 Facebook pages

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
272 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoid treatment for autism: a proof-of-concept randomized trial
Published in
Molecular Autism, February 2021
DOI 10.1186/s13229-021-00420-2
Pubmed ID
Authors

Adi Aran, Moria Harel, Hanoch Cassuto, Lola Polyansky, Aviad Schnapp, Nadia Wattad, Dorit Shmueli, Daphna Golan, F. Xavier Castellanos

X Demographics

X Demographics

The data shown below were collected from the profiles of 87 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 272 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 272 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 28 10%
Researcher 21 8%
Student > Master 19 7%
Student > Ph. D. Student 16 6%
Student > Postgraduate 11 4%
Other 46 17%
Unknown 131 48%
Readers by discipline Count As %
Medicine and Dentistry 42 15%
Pharmacology, Toxicology and Pharmaceutical Science 18 7%
Psychology 14 5%
Neuroscience 12 4%
Biochemistry, Genetics and Molecular Biology 9 3%
Other 42 15%
Unknown 135 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 103. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2023.
All research outputs
#417,641
of 25,766,791 outputs
Outputs from Molecular Autism
#38
of 719 outputs
Outputs of similar age
#12,518
of 539,879 outputs
Outputs of similar age from Molecular Autism
#3
of 25 outputs
Altmetric has tracked 25,766,791 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 719 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 539,879 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.